<?xml version="1.0" encoding="utf-8"?><rss version="2.0">
<channel>
<title>IM Vaccine</title>
<link>http://imvaccine.com/</link>
<description>IM Vaccine News Feed</description>
<category>vaccine, cancer, medical</category>
<generator></generator>
<webMaster>techsupport@impactcommuncations.ca</webMaster>
		<item>
		<title>Immunovaccine Appoints Albert Scardino as New Board Member</title>
		<link>http://imvaccine.com/releases.php?releases_id=210</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Appoints Albert Scardino as New Board Member</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA</title>
		<link>http://imvaccine.com/releases.php?releases_id=209</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Signs Agreement with Oncothyreon to Develop Cancer Vaccine</title>
		<link>http://imvaccine.com/releases.php?releases_id=208</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Signs Agreement with Oncothyreon to Develop Cancer Vaccine</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Warwick Kimmins Science Scholarship Awarded</title>
		<link>http://imvaccine.com/releases.php?releases_id=207</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Warwick Kimmins Science Scholarship Awarded</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Appoints Acting CFO</title>
		<link>http://imvaccine.com/releases.php?releases_id=206</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Appoints Acting CFO</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Announces the Departure of its Chief Financial Officer</title>
		<link>http://imvaccine.com/releases.php?releases_id=205</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Announces the Departure of its Chief Financial Officer</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine</title>
		<link>http://imvaccine.com/releases.php?releases_id=204</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Appoints Paul Kirkconnell to Board, Announces Retirement of Denis Ryan</title>
		<link>http://imvaccine.com/releases.php?releases_id=202</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Appoints Paul Kirkconnell to Board, Announces Retirement of Denis Ryan</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Announces 2010 First Quarter Results</title>
		<link>http://imvaccine.com/releases.php?releases_id=201</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Announces 2010 First Quarter Results</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute</title>
		<link>http://imvaccine.com/releases.php?releases_id=200</link>
		<date>Sat, 31 Jul 2010 00:00:00 PDT</date>
		<description>Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute</description>
		<author></author>
		<category></category>
		</item>
		 </channel>
</rss>

